Chr Hansen Holding A/S
CSE:CHR
Chr Hansen Holding A/S
Net Issuance of Common Stock
Chr Hansen Holding A/S
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Chr Hansen Holding A/S
CSE:CHR
|
Net Issuance of Common Stock
€1.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Novozymes A/S
CSE:NZYM B
|
Net Issuance of Common Stock
kr167m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Photocat A/S
STO:PCAT
|
Net Issuance of Common Stock
kr860k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
Chr Hansen Holding A/S
Glance View
Amid the lush, rolling landscapes of Denmark lies Chr. Hansen Holding A/S, a company with roots tracing back to 1874, when it was founded by the Danish pharmacist Christian D.A. Hansen. Today, Chr. Hansen stands as a global powerhouse and a vanguard in the bioscience industry, revered for its innovative approach to natural ingredient solutions. Anchored in the principles of sustainability and natural alternatives, the company specializes in producing cultures, enzymes, probiotics, and natural colors. These components are integral to a wide swath of industries—from food and beverages to health and agriculture—each product crafted to enhance taste, preservation, nutritional value, and even the health of end consumers and the environment. The engine of Chr. Hansen’s business model is its adeptness at utilizing and fermenting microorganisms, deploying them to solve real-world challenges and enrich various consumer products. This expertise manifests in lucrative partnerships and contracts with dairy producers, meat processors, and producers of dietary supplements, among others. By aligning its products with the trending consumer demand for natural and sustainable solutions, Chr. Hansen ensures robust sales and recurring revenues. Moreover, their commitment to research and development supports a continuous innovation pipeline, reinforcing their market leadership and fuelling further growth across international borders, making Chr. Hansen a quintessential example of science meeting commerce to flourish sustainably.
See Also
What is Chr Hansen Holding A/S's Net Issuance of Common Stock?
Net Issuance of Common Stock
1.9m
EUR
Based on the financial report for Aug 31, 2023, Chr Hansen Holding A/S's Net Issuance of Common Stock amounts to 1.9m EUR.
You don't have any saved screeners yet